| Date | Title | |
| Nov 07, 2011 | DURECT Corporation to Participate in Upcoming Healthcare Conferences |  |
| Nov 03, 2011 | DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of Programs | |
| Oct 26, 2011 | DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call | |
| Sep 06, 2011 | DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST) | |
| Aug 31, 2011 | DURECT Corporation to Participate in Upcoming Healthcare Conferences | |
| Aug 04, 2011 | DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs | |
| Jul 28, 2011 | DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call | |
| Jul 12, 2011 | Zogenix and DURECT Announce Development and License Agreement for Antipsychotic Product Candidate | |
| Jun 24, 2011 | Pfizer Receives Complete Response Letter from FDA for REMOXY® | |
| Jun 03, 2011 | DURECT to Present at the Jefferies Healthcare Conference | |
| Jun 02, 2011 | DURECT Announces Resignation of Chief Medical Officer | |
| May 12, 2011 | DURECT to Present at the UBS Global Specialty Pharmaceuticals Conference | |
| May 05, 2011 | DURECT Corporation Announces First Quarter 2011 Financial Results and Update of Programs | |
| Apr 28, 2011 | DURECT Corporation Invites You to Join its First Quarter 2011 Earnings Conference Call | |
| Apr 11, 2011 | DURECT Announces ELADUR(R) (TRANSDUR(R)-Bupivacaine) Phase II Study Results in Chronic Low Back Pain | |
| Mar 02, 2011 | DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results | |
| Mar 01, 2011 | DURECT to Present at Cowen and Company Health Care Conference | |
| Feb 24, 2011 | DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference Call | |
| Feb 09, 2011 | DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR(TM) (SABER(TM)-Bupivacaine) and Amendment of the Nycomed Agreement | |
| Feb 08, 2011 | DURECT Announces Launch of First FDA Approved SABER(TM)-Injectable Peptide Product | |
| Feb 07, 2011 | DURECT to Present at the BIO CEO & Investor Conference | |
| Jan 27, 2011 | REMOXY(R) New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 | |
